BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+8.9%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+8.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$3.53M+83.2%
2024$1.93M+521.6%
2023$310000.00-88.7%
2022$2.73M+21.3%
2021$2.25M-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-